The Supreme Court has maintained mail access to the abortion pill mifepristone, setting aside for now a lower court order that blocked abortion providers from prescribing the widely used drug through ...

By Daniel Wiessner May 14 (Reuters) - The U.S. Supreme Court has for now refused to block a U.S. Food and Drug Administration rule allowing the abortion pill mifepristone to be prescribed via a ...

The court rejects an antiabortion challenge to mifepristone, an FDA-approved medication for ending early pregnancies.

The Supreme Court has preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.

Nearly two-thirds of abortions in the U.S. are now induced by medication, and about one-quarter involve telemedicine.

Abortion pills can remain available through the mail for the immediate future after the Supreme Court on Thursday paused a lower court ruling that would have blocked access while a lawsuit proceeds.

Mifepristone, part of a two-drug regimen given to women to terminate a pregnancy, was approved by the FDA in 2000 and access ...

Justices Clarence Thomas and Samuel Alito dissented from the majority decision.

WASHINGTON (AP) — The Supreme Court on Thursday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues. The court’s ...